cryptotanshinone has been researched along with Diabetes Mellitus, Type 2 in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, L; Coffie, JW; Fang, Z; Gao, X; Li, C; Song, M; Wang, H; Wang, S; Zhang, L | 1 |
1 other study(ies) available for cryptotanshinone and Diabetes Mellitus, Type 2
| Article | Year |
|---|---|
Cryptotanshinone enhances wound healing in type 2 diabetes with modulatory effects on inflammation, angiogenesis and extracellular matrix remodelling.
Topics: Animals; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Extracellular Matrix; Fibroblasts; Human Umbilical Vein Endothelial Cells; Humans; Inflammation; Male; Mice; Neovascularization, Physiologic; Phenanthrenes; Time Factors; Wound Healing | 2020 |